In silico identification of natural products from Traditional Chinese Medicine for cancer immunotherapy.
Ontology highlight
ABSTRACT: Advances in immunotherapy have revolutionized treatments in many types of cancer. Traditional Chinese Medicine (TCM), which has a long history of clinical adjuvant application against cancer, is emerging as an important medical resource for developing innovative cancer treatments, including immunotherapy. In this study, we developed a quantitative and systems pharmacology-based framework to identify TCM-derived natural products for cancer immunotherapy. Specifically, we integrated 381 cancer immune response-related genes and a compound-target interaction network connecting 3273 proteins and 766 natural products from 66 cancer-related herbs based on literature-mining. Via systems pharmacology-based prediction, we uncovered 182 TCM-derived natural products having potential anti-tumor immune
SUBMITTER: Cai C
PROVIDER: S-EPMC7870934 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA